Cidara Therapeutics, Inc. (CDTX) Covered Calls

You can sell covered calls on Cidara Therapeutics, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CDTX (prices last updated Thu 4:16 PM ET):

Cidara Therapeutics, Inc. (CDTX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
19.44 +0.26 18.09 20.00 112K - 0.2
Covered Calls For Cidara Therapeutics, Inc. (CDTX)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
May 16 20 0.50 19.50 2.6% 31.6%
Jun 20 20 3.50 16.50 21.2% 119%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Cidara Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of anti-infectives for the treatment of diseases. Its lead product candidate is rezafungin acetate, a molecule in the echinocandin class of antifungals for the treatment and prevention of serious invasive fungal infections, including candidemia and invasive candidiasis, fungal infections associated with high mortality rates. It is also developing antibody-drug conjugates for multidrug-resistant bacterial infections that directly kill pathogens and also direct a patient's immune system to attack and eliminate bacterial, fungal, or viral pathogens. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in June 2014. Cidara Therapeutics, Inc. was founded in 2012 and is headquartered in San Diego, California.